Adocia ADR ADOCY
Trading Information
- Previous Close Price
- $9.80
- Day Range
- $11.80–11.80
- 52-Week Range
- $11.80–11.80
- Bid/Ask
- $0.00 / $14.22
- Shares Outstanding
- 20.31M
- Market Cap
- $231.08M
- Volume/Avg
- 812 / 812
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 111.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Adocia is a clinical-stage biotechnology company focused on developing treatments for diabetes, obesity, and related metabolic diseases. The company uses its proprietary BioChaperone, AdoShell, AdOral and AdoXLong technology platforms to develop improved formulations of therapeutic proteins and peptides, oral and long-acting metabolic treatments, and immunoprotective cell-therapy solutions. Its pipeline includes BioChaperone Lispro, BioChaperone GLP-1 Amylin, AdoXLong Sema, AdOral Sema, AdoShell Islets and M1Pram.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 80
- Website
- https://www.adocia.com
Valuation
|
Metric
|
ADOCY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 111.56 |
Price/Cash Flow | — |
Price/Earnings
ADOCY
Financial Strength
|
Metric
|
ADOCY
|
|---|---|
Quick Ratio | 0.83 |
Current Ratio | 0.88 |
Interest Coverage | −15.57 |
Quick Ratio
ADOCY
Profitability
|
Metric
|
ADOCY
|
|---|---|
Return on Assets (Normalized) | −61.82% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −189.32% |
Return on Assets
ADOCY
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|LBmHf% | LOCK|@%@HH | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|G@!@&& | LOCK|&TN?% | $83B | |||
| Moderna Inc
MRNA
| LOCK|@h!LW$ | LOCK|xpB | $80B | |||
| argenx SE ADR
ARGX
| LOCK|l%vT<q | LOCK|<wP | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@<$Wsl | LOCK|Y# | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|B%>vNRz | LOCK|ph!%^ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|%sd&>jk | LOCK|Z&%SF | $28B | |||
| Incyte Corp
INCY
| LOCK|k>!@%<? | LOCK|?>! | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|K^p!p% | LOCK|k!K | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|G<<BFFL | LOCK|x#z | $14B |
United States